AstraZeneca's Kid Asthma Drug Patent Invalid, Judge Says
A New Jersey federal judge on Monday shot down AstraZeneca PLC's bid to block four generic drugmakers from producing no-name versions of the pharmaceutical giant's pediatric asthma medication, and declared one...To view the full article, register now.
Already a subscriber? Click here to view full article